https://scholars.lib.ntu.edu.tw/handle/123456789/641599
標題: | Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes | 作者: | HUEY-LING CHEN CHIEN-NAN LEE Chang, Chin-Hao Lai, Ming-Wei Tsai, Ming-Chieh Mu, Shu-Chi CHUN-JEN LIU JIN-CHUNG SHIH Wen, Wan-Hsin Hu, Rui-Ting Huang, Chun-Pin Hu, Kuang-Chun Chen, Chie-Pein Lee, Chyi-Long Chien, Rong-Nan Chang, Kai-Chi HONG-YUAN HSU CHIEN-CHANG LEE YEN-HSUAN NI MEI-HWEI CHANG |
關鍵字: | HBV immunization; HBeAg; antiviral therapy; children; hepatitis B virus; mother-to-infant transmission; nucleoside analogue; pregnancy; pregnant women | 公開日期: | 8-三月-2024 | 來源出版物: | Liver international : official journal of the International Association for the Study of the Liver | 摘要: | The use of antiviral agents, specifically tenofovir disoproxil fumarate (TDF), in pregnant women to prevent mother-to-child HBV transmission is a key step towards hepatitis elimination. However, data on using tenofovir alafenamide (TAF) is insufficient. The frequent occurrence of postpartum ALT flares may impact the clinical implementation. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/641599 | ISSN: | 14783223 | DOI: | 10.1111/liv.15873 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。